↓ Skip to main content

Caffeine in the management of patients with headache

Overview of attention for article published in The Journal of Headache and Pain, October 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#14 of 1,562)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
37 news outlets
twitter
73 X users
facebook
1 Facebook page
wikipedia
2 Wikipedia pages
googleplus
1 Google+ user
video
1 YouTube creator

Citations

dimensions_citation
83 Dimensions

Readers on

mendeley
290 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Caffeine in the management of patients with headache
Published in
The Journal of Headache and Pain, October 2017
DOI 10.1186/s10194-017-0806-2
Pubmed ID
Authors

Richard B. Lipton, Hans-Christoph Diener, Matthew S. Robbins, Sandy Yacoub Garas, Ketu Patel

Abstract

Caffeinated headache medications, either alone or in combination with other treatments, are widely used by patients with headache. Clinicians should be familiar with their use as well as the chemistry, pharmacology, dietary and medical sources, clinical benefits, and potential safety issues of caffeine. In this review, we consider the role of caffeine in the over-the-counter treatment of headache. The MEDLINE and Cochrane databases were searched by combining "caffeine" with the terms "headache," "migraine," and "tension-type." Studies that were not placebo-controlled or that involved medications available only with a prescription, as well as those not assessing patients with migraine and/or tension-type headache (TTH), were excluded. Compared with analgesic medication alone, combinations of caffeine with analgesic medications, including acetaminophen, acetylsalicylic acid, and ibuprofen, showed significantly improved efficacy in the treatment of patients with TTH or migraine, with favorable tolerability in the vast majority of patients. The most common adverse events were nervousness (6.5%), nausea (4.3%), abdominal pain/discomfort (4.1%), and dizziness (3.2%). This review provides evidence for the role of caffeine as an analgesic adjuvant in the acute treatment of primary headache with over-the-counter drugs, caffeine doses of 130 mg enhance the efficacy of analgesics in TTH and doses of ≥100 mg enhance benefits in migraine. Additional studies are needed to assess the relationship between caffeine dosing and clinical benefits in patients with TTH and migraine.

X Demographics

X Demographics

The data shown below were collected from the profiles of 73 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 290 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 290 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 50 17%
Student > Master 23 8%
Other 20 7%
Student > Ph. D. Student 15 5%
Researcher 14 5%
Other 39 13%
Unknown 129 44%
Readers by discipline Count As %
Medicine and Dentistry 59 20%
Pharmacology, Toxicology and Pharmaceutical Science 22 8%
Nursing and Health Professions 16 6%
Biochemistry, Genetics and Molecular Biology 15 5%
Chemistry 10 3%
Other 33 11%
Unknown 135 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 344. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2024.
All research outputs
#96,911
of 25,791,495 outputs
Outputs from The Journal of Headache and Pain
#14
of 1,562 outputs
Outputs of similar age
#2,091
of 339,403 outputs
Outputs of similar age from The Journal of Headache and Pain
#3
of 15 outputs
Altmetric has tracked 25,791,495 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,562 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 339,403 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.